Molecular Cytogenetic Stratification of Recurrent Oligodendrogliomas: Utility of Interphase Fluorescence in Situ Hybridization (I-FISH)
Zuzana Zemanová1, F. Kramar2, L. Babická1, Š. Ransdorfová3, J. Melicherčíková3, P. Hrabal4, P. Kozler2, K. Michalová1,3
1Centre of Oncocytogenetics, Institute of Clinical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University, and General Teaching Hospital, Prague, Czech Republic 2Neurosurgical Department, Central Military Hospital, Prague, Czech Republic 3Institute of Haematology and Blood Transfusion, Prague, Czech Republic 4Department of Pathology and Anatomy, Central Military Hospital, Prague, Czech Republic
Received May 2006
Accepted June 2006
Crossref Cited-by Linking
Lhotska Halka, Janeckova Karolina, Cechova Hana, Macoun Jaromir, Aghova Tatiana, Lizcova Libuse, Svobodova Karla, Hodanova Lucie, Konecna Dora, Soukup Jiri, Kramar Filip, Netuka David, Zemanova Zuzana: Validating a clinically based MS-MLPA threshold through comparison with Sanger sequencing in glioblastoma patients. Clin Epigenet2025, 17. <https://doi.org/10.1186/s13148-025-01822-2>
